Bio-Rad Laboratories supplies instruments, reagents, and software for life science research and clinical diagnostics. Its products are widely used in protein and cell analysis, quality control, blood typing and transfusion medicine, and related laboratory workflows. The company serves academic labs, biopharma R&D, and clinical laboratories with a mix of recurring consumables and durable systems.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 585.4 | — | 64 | — |
| Q2 2025 | 651.6 | — | 317.8 | — |
| Q3 2025 | 653 | — | -341.9 | — |
| Q4 2025 | 693.2 | — | 720 | — |
| Q1 2026 | 592.1 | 1.1% | -527.1 | -923.6% |
| Q2 2026 | 651 | -0.1% | 371.4 | 16.9% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Elastic N.V. (ESTC), Advanced Drainage Systems, Inc. (WMS), SouthState Bank Corporation (SSB), First Majestic Silver Corp. (AG), Federal Realty Investment Trust (FRT), Dr. Reddy's Laboratories Limited (RDY)